CHIZF (China Traditional Chinese Medicine Holdings Co) Beneish M-Score: -2.80 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIZF China Traditional Chinese Medicine Holdings Co Ltd CHIZF
42 GF Score
Price $0.16
GF Value $0.36
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is China Traditional Chinese Medicine Holdings Co Beneish M-Score?

China Traditional Chinese Medicine Holdings Co CHIZF -25.51% 42 Beneish M-Score is -2.80 as of Aug. 01, 2026. GuruFocus rates CHIZF with a GF Score™ of 42/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 912 Drug Manufacturers companies, China Traditional Chinese Medicine Holdings Co ranks better than 75% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for China Traditional Chinese Medicine Holdings Co's Beneish M-Score or its related term are showing as below:

CHIZF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.44   Max: -1.68
Current: -2.8

During the past 13 years, the highest Beneish M-Score of China Traditional Chinese Medicine Holdings Co was -1.68. The lowest was -2.87. And the median was -2.44.


China Traditional Chinese Medicine Holdings Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for China Traditional Chinese Medicine Holdings Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Traditional Chinese Medicine Holdings Co Beneish M-Score Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.68 -2.48 -2.40 -2.87 -2.80

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 0.00 -2.87 0.00 -2.80

CHIZF vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's Beneish M-Score falls into.


CHIZF
42GF Score
China Traditional Chinese Medicine Holdings Co Ltd CHIZF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Traditional Chinese Medicine Holdings Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of China Traditional Chinese Medicine Holdings Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1487+0.528 * 0.9895+0.404 * 0.9548+0.892 * 0.9232+0.115 * 0.915
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0494+4.679 * -0.081088-0.327 * 0.894
=-2.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $1,214 Mil.
Revenue was $2,093 Mil.
Gross Profit was $1,007 Mil.
Total Current Assets was $2,514 Mil.
Total Assets was $4,593 Mil.
Property, Plant and Equipment(Net PPE) was $1,022 Mil.
Depreciation, Depletion and Amortization(DDA) was $165 Mil.
Selling, General, & Admin. Expense(SGA) was $862 Mil.
Total Current Liabilities was $1,098 Mil.
Long-Term Debt & Capital Lease Obligation was $37 Mil.
Net Income was $-49 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $324 Mil.
Total Receivables was $1,145 Mil.
Revenue was $2,268 Mil.
Gross Profit was $1,079 Mil.
Total Current Assets was $2,588 Mil.
Total Assets was $4,816 Mil.
Property, Plant and Equipment(Net PPE) was $1,069 Mil.
Depreciation, Depletion and Amortization(DDA) was $155 Mil.
Selling, General, & Admin. Expense(SGA) was $890 Mil.
Total Current Liabilities was $1,071 Mil.
Long-Term Debt & Capital Lease Obligation was $260 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1214.412 / 2093.477) / (1145.089 / 2267.599)
=0.580093 / 0.504979
=1.1487

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1079.059 / 2267.599) / (1006.805 / 2093.477)
=0.47586 / 0.480925
=0.9895

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2514.241 + 1022.33) / 4592.718) / (1 - (2587.595 + 1068.502) / 4815.982)
=0.229961 / 0.240841
=0.9548

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2093.477 / 2267.599
=0.9232

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(155.236 / (155.236 + 1068.502)) / (164.537 / (164.537 + 1022.33))
=0.126854 / 0.138631
=0.915

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(861.865 / 2093.477) / (889.603 / 2267.599)
=0.411691 / 0.392311
=1.0494

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((36.946 + 1098.021) / 4592.718) / ((259.827 + 1071.353) / 4815.982)
=0.247123 / 0.276409
=0.894

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-48.567 - 0 - 323.849) / 4592.718
=-0.081088

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

China Traditional Chinese Medicine Holdings Co has a M-score of -2.80 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.80 mean?
China Traditional Chinese Medicine Holdings Co (CHIZF) has a Beneish M-Score of -2.80 as of Aug. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. According to the industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #228 out of 912 companies in the Drug Manufacturers industry, placing it in the top 25%.
Is China Traditional Chinese Medicine Holdings Co's Beneish M-Score too high?
China Traditional Chinese Medicine Holdings Co's current Beneish M-Score is -2.80. Based on the distribution chart, China Traditional Chinese Medicine Holdings Co ranks #228 out of 912 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Traditional Chinese Medicine Holdings Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does China Traditional Chinese Medicine Holdings Co's Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #228 out of 912 companies for Beneish M-Score. This places China Traditional Chinese Medicine Holdings Co in the top 25% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. China Traditional Chinese Medicine Holdings Co's current Beneish M-Score is -2.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Traditional Chinese Medicine Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co (CHIZF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.16 — trading 54.7% below its estimated fair value. The current Beneish M-Score is -2.80. China Traditional Chinese Medicine Holdings Co's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For China Traditional Chinese Medicine Holdings Co (CHIZF), the current Beneish M-Score is -2.80 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Traditional Chinese Medicine Holdings Co (CHIZF) Overvalued in 2026?

Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co stock appears to be undervalued. The current stock price of $0.16 is trading 54.7% below its estimated GF Value™ of $0.36. GuruFocus considers China Traditional Chinese Medicine Holdings Co to be Possible Value Trap.

Key valuation signals for CHIZF:

  • Beneish M-Score: -2.80
  • GF Value™: $0.36 vs. price of $0.16 (54.7% below fair value)
  • GF Score™: 42/100 with 5 warning signs

No single metric tells the full story. See the CHIZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Traditional Chinese Medicine Holdings Co Business Description

Other Exchanges 00570:Hong Kong
Address 288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.
42GF Score

Get the complete analysis for CHIZF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$0.36
GF Value